Arrhythmias and mortality after myocardial infarction in diabetic patients: Relationship to diabetes treatment

Diabetes Care

Volumn 21, Issue 4, 1998, Pages 637-340

  Davis, Timothy M E ^a   Parsons, Richard W ^a   Broadhurst, Robin J ^a   Hobbs, Michael S T ^a   Jamrozik, Konrad ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIGITALIS; DIURETIC AGENT; GLIBENCLAMIDE; GLICLAZIDE; INSULIN; SULFONYLUREA;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; ARRHYTHMIA; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIGITALIS GLYCOSIDES; DIURETICS; FEMALE; GLICLAZIDE; HEART BLOCK; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; INSULIN; MALE; METFORMIN; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PULMONARY EDEMA; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SMOKING; SURVIVAL RATE; TIME FACTORS;

EID: 0031921750     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.4.637     Document Type: Article

References (23)

1. Yudkin JS, Hendra TJ: Vascular events and diabetes: acute myocardial infarction and stroke. In International Textbook of Diabetes Mellitus. 1st ed. Alberti KGMM, Defronzo RA, Keen H, Zimmet P, Eds. London, John Wiley, 1992, p. 1185-1210
2. Colwell JA, Lopes-Virella MF: A review of the development of large-vessel disease in diabetes mellitus. Am J Med 85 (Suppl. 5A): 113-118, 1988
3. Smits P, Thien T: Cardiovascular effects of sulphonylurea derivatives: implications for the treatment of NIDDM? Diabetologia 38:116-121, 1995
4. Leibowitz G, Cerasi E: Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing? Diabetologia 39:503-514, 1996
5. Diabetes Control and Complications Trial Group: Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. Am J Cardiol 75: 894-903, 1995
6. University Group Diabetes Program: Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. 4. A preliminary report on phenformin results. JAMA 217:777-784, 1971
7. Tzagouris M, Reynertson R: Mortality from coronary artery disease during phenformin therapy. Ann Intern Med 76:587-592, 1972
8. University Group Diabetes Program: A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. 2. Mortality results. Diabetes 19 (Suppl. 2):785-830, 1970
9. Soler NG, Bennett MA, Pentecost BL, Fitzgerald MG, Malins JM: Myocardial infarction in diabetics. Q J Med 44:125-132, 1975
10. Czyzyk A, Krolewski A, Szablowska S, Alot A, Kopczynski J: Clinical course of myocardial infarction among diabetic patients. Diabetes Care 3:526-529, 1980
11. Kereiakes DJ: Myocardial infarction in the diabetic patients. Clin Cardiol 8:446-450, 1985
12. Kilo C, Miller L, Williamson J: The crux of the UGDP: spurious results and biologically inappropriate data analysis. Diabetologia 18:179-185, 1980
13. Jarrett RJ, McCartney P, Keen H: The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia 22:79-84, 1982
14. Yudkin J, Oswald G: Determinants of hospital admission and case fatality in diabetic patients with myocardial infarction. Diabetes Care 11:351-358, 1988
15. Ohneda A, Maruhama Y, Itabashi H, Oikawa SI, Kobayashi T, Horigome K, Chiba M, Kai Y, Sakai T, Okuguchi F, Nihei J: Vascular complications and long-term administration of oral hypoglycemic agents in patients with diabetes mellitus. Tohoku J Exp Med 124:205-222, 1978
16. Pogatsa G, Koltai M, Jermedy G, Simon J, Aranyi Z, Ballagi-Pordany A: The effect of sulfonylurea therapy on the outcome of coronary artery disease in diabetic patients. Acta Medica Hungaria 49:39-51, 1992
17. World Health Organization MONICA Project: Myocardial infarction and coronary deaths in the World Health Organization MONICA project: registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90:482-612, 1994
18. Glatthaar C, Welbom T, Stenhouse N, Garcia-Webb P: Diabetes and impaired glucose tolerance: a prevalence estimate based on the 1981 Busselton survey. Med J Aust 143:436-440, 1985
19. Davis TME, Hughes-Anderson WA: Effect of an intensive education programme on clinical management of diabetic inpatients. Pract Diabetes Int 13:110-114, 1996
20. Margolis JR, Kannel WB, Feinleib M, Dawber TR, McNamara PM: Clinical features of unrecognized myocardial infarction: silent and symptomatic: eighteen year follow-up: the Framingham Study. Am J Cardiol 32:1-5, 1973
21. Pogatsa G: Potassium channels in the cardiovascular system. Diabetes Res Clin Pract 28(Suppl.):91-98, 1995
22. Malmberg K, Ryden L, Hamsten A, Herlitz J, Waldenstrom A, Wedel H: Effects of insulin on cause specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. Eur Heart J 17:1298-1301, 1996
23. Cacciapuoti F, Spiezia R, Bianchi U, Lama D, D'Avino M, Varricchio M: Effectiveness of glibenclamide on myocardial ischemic ventricular arrhythmias in non-insulin-dependent diabetes mellitus. Am J Cardiol 67:843-847, 1991